[go: up one dir, main page]

PT1119363E - Composicao contendo carnitina e fosfato de inositol util como suplemento de dieta ou farmaco - Google Patents

Composicao contendo carnitina e fosfato de inositol util como suplemento de dieta ou farmaco

Info

Publication number
PT1119363E
PT1119363E PT00922866T PT00922866T PT1119363E PT 1119363 E PT1119363 E PT 1119363E PT 00922866 T PT00922866 T PT 00922866T PT 00922866 T PT00922866 T PT 00922866T PT 1119363 E PT1119363 E PT 1119363E
Authority
PT
Portugal
Prior art keywords
util
inositol
pharmacy
diet
supplement
Prior art date
Application number
PT00922866T
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of PT1119363E publication Critical patent/PT1119363E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
PT00922866T 1999-04-22 2000-04-19 Composicao contendo carnitina e fosfato de inositol util como suplemento de dieta ou farmaco PT1119363E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000248A IT1306133B1 (it) 1999-04-22 1999-04-22 Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.

Publications (1)

Publication Number Publication Date
PT1119363E true PT1119363E (pt) 2005-09-30

Family

ID=11406708

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00922866T PT1119363E (pt) 1999-04-22 2000-04-19 Composicao contendo carnitina e fosfato de inositol util como suplemento de dieta ou farmaco

Country Status (26)

Country Link
US (1) US6565876B1 (pt)
EP (1) EP1119363B1 (pt)
JP (1) JP2002542282A (pt)
KR (1) KR20010053023A (pt)
CN (1) CN1359295A (pt)
AR (1) AR023391A1 (pt)
AT (1) ATE299370T1 (pt)
AU (1) AU776591B2 (pt)
BR (1) BR0006076A (pt)
CA (1) CA2335015C (pt)
DE (1) DE60021247T2 (pt)
DK (1) DK1119363T3 (pt)
EE (1) EE200000742A (pt)
ES (1) ES2243254T3 (pt)
HU (1) HU227357B1 (pt)
IL (1) IL140164A0 (pt)
IS (1) IS5763A (pt)
IT (1) IT1306133B1 (pt)
NO (1) NO20006429L (pt)
PL (1) PL197885B1 (pt)
PT (1) PT1119363E (pt)
SI (1) SI1119363T1 (pt)
SK (1) SK19322000A3 (pt)
TN (1) TNSN00083A1 (pt)
TR (1) TR200003737T1 (pt)
WO (1) WO2000064426A2 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316997B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
DE10129502A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US20090169585A1 (en) * 2003-10-23 2009-07-02 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
PL1863495T3 (pl) * 2005-03-18 2015-06-30 Normoxys Inc Sól wapniowa 1,6:2,3:4,5-tripirofosforanu mioinozytolu jako efektor allosteryczny hemoglobiny w leczeniu raka
ES2280136B1 (es) * 2006-02-17 2008-08-16 Universitat De Les Illes Balears Asociacion a dosis fija de fitato y zinc.
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
JP5281268B2 (ja) * 2007-10-31 2013-09-04 花王株式会社 筋力向上剤
JP2012508267A (ja) * 2008-11-11 2012-04-05 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ セルライトの処置に有用な化合物
PT2582368T (pt) * 2010-06-16 2018-06-04 Alfasigma Spa Acetil-carnitina, para utilização num método para o aumento da neurogénese em tecido neuronal
ES2495666B1 (es) * 2013-03-15 2015-08-10 Laboratoris Sanifit, S.L. Uso de derivados con enlaces c-o-p en pacientes con fallo renal
KR102141971B1 (ko) * 2018-11-12 2020-08-06 주식회사 노암 항암용 조성물
EP3973030A4 (en) * 2019-05-23 2023-05-31 Ekyj Consulting II, LLC COMPOSITIONS AND METHODS FOR THE TREATMENT AND RELIEF OF ALCOHOLIC-INDUCED SKIN REMOVAL

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
JP2001511153A (ja) * 1997-02-04 2001-08-07 ブイ． コスバブ，ジョン 血管変性性疾患の予防および処置のための組成物および方法
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition

Also Published As

Publication number Publication date
HU227357B1 (en) 2011-04-28
TR200003737T1 (tr) 2001-07-23
PL197885B1 (pl) 2008-05-30
US6565876B1 (en) 2003-05-20
NO20006429L (no) 2001-02-20
PL346160A1 (en) 2002-01-28
CA2335015C (en) 2008-03-18
HUP0102926A3 (en) 2002-12-28
DK1119363T3 (da) 2005-10-17
ITRM990248A1 (it) 2000-10-22
WO2000064426A2 (en) 2000-11-02
SK19322000A3 (sk) 2001-06-11
AU4313500A (en) 2000-11-10
ATE299370T1 (de) 2005-07-15
BR0006076A (pt) 2001-03-20
DE60021247T2 (de) 2006-04-27
DE60021247D1 (de) 2005-08-18
CN1359295A (zh) 2002-07-17
SI1119363T1 (en) 2005-10-31
EP1119363B1 (en) 2005-07-13
IL140164A0 (en) 2002-02-10
EP1119363A2 (en) 2001-08-01
IT1306133B1 (it) 2001-05-30
AR023391A1 (es) 2002-09-04
CA2335015A1 (en) 2000-11-02
JP2002542282A (ja) 2002-12-10
HUP0102926A2 (hu) 2002-03-28
ES2243254T3 (es) 2005-12-01
IS5763A (is) 2000-12-08
KR20010053023A (ko) 2001-06-25
AU776591B2 (en) 2004-09-16
EE200000742A (et) 2002-04-15
NO20006429D0 (no) 2000-12-15
TNSN00083A1 (fr) 2005-11-10
WO2000064426A3 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
PT1119363E (pt) Composicao contendo carnitina e fosfato de inositol util como suplemento de dieta ou farmaco
HUP0004534A3 (en) Pharmaceutical formulation containing olanzapine
PT1066027E (pt) Composicao farmaceutica de topiramato
HUP0103513A3 (en) Novel amidine derivatives their preparation and application as medicines and pharmaceutical compositions containing same
PL343522A1 (en) Bicyclic hydroxamic acid derivatives
HUP0101530A3 (en) Pharmaceutical compositions containing indolyl-3-glyoxylic acid derivatives with antitumoral activity
HUP0104766A3 (en) Aza-bicycles which modulate the inhibition of cell adhesion and medicaments containing them
HUP0000657A3 (en) N-arylsulfonyl-piperidine, -morpholine hydroxamic acid derivatives and pharmaceutical compositions containing them
DE69800469D1 (de) Pulverförmige ascorbinsaüre enthaltende kosmetische und/oder dermatologische zusammensetzung
PT1006110E (pt) Derivados de acil-piperazinil-pirimidinas sua preparacao e aplicacao como medicamentos
IL123143A (en) Pharmaceutical compositions containing mupirocin
HUP9800147A3 (en) Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them
IL133928A0 (en) Pharmaceutical composition containing peptichemio
HUP0001061A3 (en) Naphthylsulfonic acid derivatives and pharmaceutical compositions containing them
NO20003073L (no) Farmasøytiske blandinger inneholdende mikroniserte bisykliske legemidler
HUP0104859A2 (en) Heterocyclic compound containing sulphur and pharmaceutical compositions containing them
HU9802716D0 (en) Pharmaceutical composition of analgesic activity
PT1097159E (pt) Utilizacao de derivados de acidos fosfinicos e fosfonicos como medicamentos
ATE322880T1 (de) Zweikomponentenzusammensetzungen zur kosmetischen oder pharmazeutischen verwendung
ZA992357B (en) Photochemical synthesis of insoluble µ Sulphur.
AU5254499A (en) Ozone destroying compositions of improved tolerance to sulfur poisoning
HU9701093D0 (en) Pharmaceutical composition containing huminic acid
ZA981441B (en) Process for preparation of heterocyclic thiol
HU9700442D0 (en) Compounds of pharmaceutical activity
FR2796186B1 (fr) Distributeur de cartes rigides ou relativement rigides